• Home
  •  / Oxford Nanopore Technologies

Oxford Nanopore Technologies

OverviewSuggest Edit

Oxford Nanopore Technologies is a company that develops a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins. The handheld MinION device, the high-throughput and high sample number PromethION and GridION systems are designed to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows and direct analysis of the molecule of interest. The devices may be used in scientific research, personalized medicine, crop science, security and defense, and environmental applications.
TypePrivate
Founded2005
HQOxford, GBMap
Websitenanoporetech.com
Employee Ratings3.8More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2021)477(+2%)
Revenue (FY, 2018)£32.5 M(+136%)
Cybersecurity ratingCMore

Key People/Management at Oxford Nanopore Technologies

Gordon Sanghera

Gordon Sanghera

Chief Executive Officer and Board Member
Alan Aubrey

Alan Aubrey

Non-Executive Director
Sarah Gordon Wild

Sarah Gordon Wild

Non-Executive Director
Spike Willcocks

Spike Willcocks

Chief BD Officer and Board Member
John Schoellerman

John Schoellerman

SVP, Corporate Development and Investment
Tim Cowper

Tim Cowper

VP, Finance
Show more

Oxford Nanopore Technologies Office Locations

Oxford Nanopore Technologies has offices in Oxford, Harwell Campus, Little Chesterford, Cambridge and in 4 other locations
Oxford, GB (HQ)
Magdalen Centre, Robert Robinson Ave, Littlemore
Harwell Campus, GB
Quad 1, First Floor, Becquerel Ave
Chuo City, JP
Nihonbashihoridomecho
Singapore, SG
60 Biopolis St, Genome
Cambridge, MA, US
One Kendall Square, Binney St
New York, NY, US
101 6th Ave
Show all (9)

Oxford Nanopore Technologies Financials and Metrics

Summary Metrics

Founding Date

2005

Oxford Nanopore Technologies total Funding

$975.5 m

Oxford Nanopore Technologies latest funding size

$145.16 m

Time since last funding

a year ago

Oxford Nanopore Technologies investors

GIC, Illumina, Top Technology Ventures, Amgen, IP Group Plc, IP Venture Fund, Woodford Investment Management, Lansdowne Partners, Odey Asset Management, Invesco, CCB International, GT Healthcare, Hostplus
Oxford Nanopore Technologies's latest funding round in January 2020 was reported to be $145.2 m. In total, Oxford Nanopore Technologies has raised $975.5 m. Oxford Nanopore Technologies's latest valuation is reported to be $1.6 b.
View all funding rounds

Oxford Nanopore Technologies Revenue

Oxford Nanopore Technologies's revenue was reported to be £32.52 m in FY, 2018
GBP

Revenue (FY, 2018)

32.5m

Gross profit (FY, 2018)

16.0m

Gross profit margin (FY, 2018), %

49.2%

Net income (FY, 2018)

(53.1m)

EBITDA (FY, 2018)

(62.4m)

EBIT (FY, 2018)

(62.7m)

Market valuation

1.6b

Cash (31-Dec-2018)

35.3m
GBPFY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

181.6k158.5k361.2k167.9k90.3k149.5k746.0k4.5m13.8m32.5m

Cost of goods sold

564.0k3.7m7.1m16.5m

Gross profit

182.0k867.0k6.7m16.0m

Gross profit Margin, %

24%19%49%49%
show all
GBPFY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

7.7m6.4m14.0m20.3m16.2m6.7m21.9m28.1m24.9m52.6m64.1m57.8m35.3m

Accounts Receivable

4.7k188.2k78.5k1.4m4.4m10.9m

Inventories

22.0k340.0k6.4m18.6m

Current Assets

7.8m6.7m14.8m21.9m26.3m37.9m50.4m67.5m68.3m106.9m155.5m97.9m142.3m
show all
GBPFY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(560.2k)(1.0m)(2.6m)(6.2m)(9.9m)(13.7m)(19.2m)(24.2m)(37.0m)(38.5m)(59.1m)(56.5m)(53.1m)

Cash From Operating Activities

(1.3m)(2.5m)(6.9m)(10.0m)(12.8m)(21.3m)(23.3m)(33.9m)(33.1m)(51.2m)(66.3m)(56.1m)

Cash From Financing Activities

25.0k10.0m13.9m17.3m24.9m31.7m39.7m34.9m70.4m80.1m79.7m50.8m

Net Change in Cash

(1.3m)7.6m6.3m9.1m(9.5m)15.2m6.2m(3.3m)27.7m11.4m(6.2m)(22.5m)
show all
GBPFY, 2006

Financial Leverage

1 x
Show all financial metrics

Oxford Nanopore Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset

C

75/100

Learn more about our premium products
SecurityScorecard logo

Oxford Nanopore Technologies Online and Social Media Presence

Oxford Nanopore Technologies's Trends

Embed Graph

Oxford Nanopore Technologies Blogs

January 05, 2021

Diagnostic accuracy of Loop mediated isothermal amplification coupled to Nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations

Diagnostic accuracy of Loop mediated isothermal amplification coupled to Nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations jessica.davies… Tue, 01/05/2021 - 16:45
November 05, 2020

Targeted long-read sequencing resolves complex structural variants and identifies missing disease-causing variants

Targeted long-read sequencing resolves complex structural variants and identifies missing disease-causing variants jessica.davies… Thu, 11/05/2020 - 09:31
October 12, 2020

Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing

Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing jessica.davies… Mon, 10/12/2020 - 11:55
September 24, 2020

Unraveling molecular mechanisms of immunity and cancer-resistance using the genomes of the Neotropical bats Artibeus jamaicensis and Pteronotus mesoamericanus

Unraveling molecular mechanisms of immunity and cancer-resistance using the genomes of the Neotropical bats Artibeus jamaicensis and Pteronotus mesoamericanus tom.coey@nanop… Thu, 09/24/2020 - 10:49
September 11, 2020

The structure, function, and evolution of a complete human chromosome 8

The structure, function, and evolution of a complete human chromosome 8 jessica.davies… Fri, 09/11/2020 - 09:53
August 12, 2020

Long-read sequencing to understand genome biology and cell function

Long-read sequencing to understand genome biology and cell function tom.coey@nanop… Wed, 08/12/2020 - 12:12
Show more

 Oxford Nanopore Technologies Frequently Asked Questions

  • When was Oxford Nanopore Technologies founded?

    Oxford Nanopore Technologies was founded in 2005.

  • Who are Oxford Nanopore Technologies key executives?

    Oxford Nanopore Technologies's key executives are Gordon Sanghera, Alan Aubrey and Sarah Gordon Wild.

  • How many employees does Oxford Nanopore Technologies have?

    Oxford Nanopore Technologies has 477 employees.

  • What is Oxford Nanopore Technologies revenue?

    Latest Oxford Nanopore Technologies annual revenue is £32.5 m.

  • What is Oxford Nanopore Technologies revenue per employee?

    Latest Oxford Nanopore Technologies revenue per employee is £68.2 k.

  • Who are Oxford Nanopore Technologies competitors?

    Competitors of Oxford Nanopore Technologies include Pacific Biosciences of California, Complete Genomics and KaloCyte.

  • Where is Oxford Nanopore Technologies headquarters?

    Oxford Nanopore Technologies headquarters is located at Magdalen Centre, Robert Robinson Ave, Littlemore, Oxford.

  • Where are Oxford Nanopore Technologies offices?

    Oxford Nanopore Technologies has offices in Oxford, Harwell Campus, Little Chesterford, Cambridge and in 4 other locations.

  • How many offices does Oxford Nanopore Technologies have?

    Oxford Nanopore Technologies has 9 offices.